Dr. Aysun Ertaş
Check-ups & DiagnosticsVerified
- 23+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Genetic Testing
Genetic screening
What genetic screening is, how next-generation DNA sequencing identifies gene variants, and what evidence shows regarding clinical accuracy. Compare targeted panels with whole exome sequencing, review approximate costs in Turkey against the UK, US and Germany, and understand carrier tests, hereditary cancer risks, sample collection timelines, lab accreditations and the role of genetic counselling.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Genetic Testing
- Hospitals
- 2
- Verified
- 2
- Price from
- Price on request
Verified surgeons for Genetic Screening
2 doctors Compare doctors, ratings and prices — ask any of them for a free quote.
Uzm. Dr. Türkan Özer
Check-ups & DiagnosticsVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Genetic screening in Turkey: what it is and how DNA analysis works
Genetic screening is a laboratory testing process that analyses an individual's DNA to identify inherited gene mutations, chromosomal variations, or carrier markers. Using next-generation sequencing (NGS) and targeted molecular panels, clinicians evaluate susceptibility to hereditary cancers, inherited cardiac disorders, or recessive conditions passed to children. Testing is performed on a standard blood sample or buccal saliva swab. International patients seeking genetic screening Turkey packages often combine DNA analysis with routine diagnostics; see our guide to checkup treatments in Turkey.
Unlike standard blood tests measuring biochemical markers, understanding what is genetic screening involves examining how laboratories inspect your inherited genetic code. It provides long-term risk assessment before symptoms arise rather than acute treatment. This guide explains how sequencing works, clinical accuracy, approximate costs in Turkey against the UK, US and Germany, turnaround times, and how to verify laboratory accreditations.
How does genetic screening work in a clinical laboratory?
Clinical genetic testing follows a multi-stage workflow to ensure analytical precision. The process begins with a consultation where a medical geneticist reviews your three-generation family pedigree and health goals to choose an appropriate panel.
The laboratory workflow involves five key steps:
- Sample collection: A nurse collects a venous blood sample in an EDTA tube or a buccal saliva swab.
- DNA extraction: The laboratory isolates genomic DNA and measures its purity and concentration.
- Sequencing: Target genomic regions are enriched and processed with high-throughput Next-Generation Sequencing (NGS).
- Bioinformatic alignment: Software aligns the sequence against human reference genomes to detect variants.
- Medical curation: A certified clinical geneticist interprets detected variants against global clinical databases to produce a formal report.
Sample collection takes fifteen minutes, after which all sequencing and bioinformatic analysis take place in specialised molecular laboratories.
Does genetic screening work and how accurate are the results?
Yes, clinical genetic testing works reliably for identifying sequence variations. Modern next-generation sequencing achieves analytical accuracy exceeding 99% for single nucleotide variants in targeted regions. Professional bodies like the European Society of Human Genetics (ESHG) recognize targeted sequencing as an established tool for assessing hereditary conditions.
However, analytical accuracy differs from clinical prediction. Findings are classified into five standard categories: pathogenic, likely pathogenic, variant of uncertain significance (VUS), likely benign, or benign. A pathogenic finding indicates elevated risk rather than a certainty of developing disease due to variable penetrance.
A negative result lowers risk within examined genes but cannot eliminate disease risk entirely due to unsequenced regions and non-genetic factors. A trustworthy clinic will never promise absolute disease immunity.
Genetic screening cost in Turkey compared with the UK, US and Germany
The table below outlines approximate cost ranges for clinical genetic panels across Turkey, the UK, the US, and Germany. These reflect wide market estimates for multi-gene panels and exome analysis rather than single-gene tests.
| Country | Approximate cost range |
|---|---|
| Turkey | €450 – €2,200 |
| United Kingdom | €1,200 – €4,500 |
| United States | €1,500 – €6,000 |
| Germany | €1,100 – €4,200 |
Several factors affect the final genetic screening cost. The genetic screening price depends on test scope: a focused 30-gene panel requires fewer resources than whole exome sequencing of roughly 20,000 genes. Sequencing depth and express reporting also influence price.
Packages in Turkey generally include pre-test consultations, blood collection, sequencing, an English report, and a post-test specialist consultation. Request a written breakdown through our free quote page.
Targeted gene panels, whole exome sequencing or direct-to-consumer tests?
Choosing the appropriate testing method depends on your clinical goals. The table below compares the primary approaches:
| Screening method | Best suited to | Typical limits |
|---|---|---|
| Targeted gene panels | Specific family history (e.g. BRCA1/2, Lynch syndrome, cardiac panels) | Examines only predefined genes; misses mutations outside the panel |
| Whole exome sequencing (WES) | Complex, unexplained symptoms or broad multi-system investigation | Higher cost; higher likelihood of variants of uncertain significance |
| Direct-to-consumer genotyping | General ancestry and recreational trait exploration | Not clinically diagnostic; limited variant coverage without medical validation |
Targeted panels offer deep coverage and focused findings, making them the primary choice for cancer or cardiac screening. Whole exome sequencing investigates all coding genes but uncovers more ambiguous variants. Direct-to-consumer kits use limited genotyping without medical oversight and are not suitable for clinical decisions.
Which conditions and markers can genetic screening detect?
Clinical genetic screening focuses on well-characterized genes where identification of a mutation informs proactive surveillance. Common categories include:
- Hereditary cancer syndromes: Panels checking BRCA1, BRCA2, and PALB2 for breast and ovarian cancer, or MLH1 and MSH2 for Lynch syndrome.
- Cardiovascular conditions: Screening for inherited cardiomyopathies, familial hypercholesterolaemia, and Long QT syndrome.
- Carrier screening: Identifying recessive carrier status for cystic fibrosis, spinal muscular atrophy, and thalassaemia to guide reproductive decisions.
- Pharmacogenomics: Evaluating liver enzyme variations (such as CYP enzymes) that influence medication metabolism and dosing.
Many patients combine genetic testing with physical examinations and blood profiles; explore our guide to a comprehensive diagnostic check-up to see how diagnostics integrate.
Who is an appropriate candidate for genetic screening, and who is not?
Genetic screening is appropriate for individuals with clear medical or reproductive motivations. Good candidates include:
- Adults with a personal or family history of early-onset cancer (such as breast or colorectal cancer diagnosed before age 50).
- Individuals with multiple relatives affected by hereditary cardiac conditions or rare genetic disorders.
- Couples planning pregnancy who want preconception carrier screening for recessive conditions.
- Proactive individuals seeking personalized medical surveillance based on genetic predispositions.
Genetic screening is not appropriate for individuals in an acute medical emergency requiring immediate hospitalization. It also does not suit those seeking an absolute guarantee of lifelong health, or individuals uncomfortable with the possibility of ambiguous findings who prefer not to undergo genetic counselling.
Your trip to Turkey and test turnaround times step by step
Regarding genetic screening recovery, because the procedure involves only a simple venous blood draw or saliva swab, there is no physical recovery period. Patients experience zero downtime, no activity restrictions, and can immediately resume their daily schedule.
A typical trip to Turkey follows these steps:
- Day 1: Arrival in Turkey, hotel check-in, and transfer.
- Day 2: Consultation with the medical geneticist, family pedigree review, and blood collection (30–45 minutes).
- Day 3: Departure home or optional sightseeing. Most patients stay two to three nights.
- Weeks 2 to 4: Laboratory sequencing, variant curation, and delivery of your English medical report.
- Teleconsultation: A secure video consultation with the geneticist to review findings and recommended health surveillance.
To understand travel logistics and clinic appointments, read how our process works.
Risks, limitations and incidental findings of genetic screening
Physical risks from genetic screening are minimal, limited to minor bruising at the blood collection site. The primary considerations are psychological and informational.
The most frequent challenge is finding a Variant of Uncertain Significance (VUS). A VUS is a DNA alteration whose link to disease is unproven; it may represent a harmless benign variation or a rare pathogenic mutation. Discovering a VUS can cause anxiety without offering clear clinical guidance, though laboratories often reclassify them as research progresses.
Broad sequencing may also uncover secondary or incidental findings unrelated to the original reason for testing, such as an unsuspected cardiac mutation. Professional guidelines allow patients to opt in or out of receiving actionable secondary findings. Finally, residual risk remains because no test checks every genomic region, meaning a normal screen does not guarantee zero disease risk.
How to choose an accredited genetics laboratory and medical geneticist
Selecting an accredited laboratory ensures reliable sequencing and rigorous clinical interpretation. Look for facilities accredited under ISO 15189, CAP, or CLIA standards, where results are reviewed and signed by certified clinical geneticists and molecular pathologists rather than automated algorithms alone.
Red flags include clinics selling panels without genetic counselling, claims of complete disease prevention, unitemized quotes, and vague data privacy policies. Trusted centres never share your genetic data with third parties.
Before proceeding, ask the clinic these questions:
- Which specific genes and variants does the panel cover?
- What sequencing platform and read depth does the laboratory use?
- Is the laboratory accredited under ISO 15189 or CAP standards?
- Is a post-test consultation with a medical geneticist included?
- What is the typical turnaround time for the validated English report?
- How are variants of uncertain significance handled in future reviews?
Review how the diagnostic process works, or request a detailed testing outline via our free quote form to speak with a coordinator.
Hospitals with Check-ups & Diagnostics in Turkey
Frequently asked questions
Genetic screening is a medical analysis of an individual's DNA, using next-generation sequencing to identify inherited gene mutations, chromosomal variations, or carrier traits. It helps assess inherited health risks, such as hereditary cancers or cardiac conditions, and supports reproductive planning by checking carrier status before pregnancy.
Yes, modern next-generation sequencing provides analytical accuracy exceeding 99% for identifying DNA sequence variants within targeted genes. However, screening identifies probabilistic susceptibility or carrier status rather than diagnosing active disease. A negative result reduces risk but cannot eliminate it entirely, which is why clinical genetic counselling is essential.
Genetic screening in Turkey typically costs between €450 and €2,200, compared with €1,200 to €4,500 in the UK. The price depends on whether you choose a targeted gene panel, a multi-gene cancer panel, or whole exome sequencing, as well as included specialist geneticist consultations and detailed bioinformatic reports.
Results arrive as a formal laboratory report classifying identified DNA variants according to international guidelines: pathogenic, likely pathogenic, variant of uncertain significance (VUS), likely benign, or benign. The report explains what each finding means for your personal health and whether follow-up clinical monitoring or family testing is recommended.
There is no physical recovery period required after genetic screening. Sample collection involves only a standard venous blood draw or a gentle saliva swab, allowing you to resume normal daily activities immediately. The primary timeline involves laboratory processing and bioinformatic analysis, which usually takes between two and four weeks.
Genetic screening causes minimal discomfort. Blood collection involves a brief needle prick in the arm, comparable to any routine blood check, with minor tenderness or bruising that clears quickly. If a buccal swab or saliva sample is used instead, the collection process is completely non-invasive and causes no physical discomfort at all.
Your primary DNA sequence remains unchanged throughout your lifetime, meaning the raw genetic data does not expire. However, medical understanding of specific gene variants evolves. Laboratories or medical geneticists may periodically re-evaluate previously identified variants of uncertain significance as scientific databases expand and provide clearer clinical interpretations over time.
Yes, the physical sample collection carries virtually no medical risk. Accredited diagnostic laboratories adhere to strict international data protection standards, ensuring your genomic data remains confidential and secure. Prior to testing, ethical guidelines require clear informed consent detailing how your DNA sample is processed, stored, or disposed of after analysis.
A targeted panel sequences specific genes associated with particular conditions, such as hereditary breast cancer or cardiac disorders, offering high sequencing depth at a lower price. Whole exome sequencing analyses all protein-coding regions across approximately 20,000 genes, providing broader investigation but generating more ambiguous variants that require extensive clinical interpretation.
Most international patients stay in Turkey for two to three nights. This allows sufficient time for an initial clinical consultation with a medical geneticist, sample collection, and any complementary health assessments. Once the blood or saliva sample is submitted, patients can fly home, receiving final reports and teleconsultations remotely.
Patient stories